Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.73 USD | -1.30% | -0.35% | +12.49% |
Feb. 28 | Kiniksa Pharmaceuticals' Q4 Earnings, Revenue Increase | MT |
Feb. 28 | Transcript : Kiniksa Pharmaceuticals, Ltd., Q4 2023 Earnings Call, Feb 28, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.49% | 1.39B | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |
- Stock
- Equities
- Stock Kiniksa Pharmaceuticals, Ltd. - Nasdaq
- News Kiniksa Pharmaceuticals, Ltd.
- Kiniksa Pharmaceuticals Q2 Net Loss Narrows, Revenue Higher; Enters License Agreement With Roche, Genentech; Shares Rise